NCT02759861View on ClinicalTrials.gov

Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

August 1, 2020

Study Completion Date

October 1, 2020

Conditions
Genotype 1 Hepatitis C Virus
Interventions
DRUG

harvoni

8 or 12 weeks of harvoni therapy with monthly nursing visiting to monitor alcohol and adherence of harvoni therapy

Trial Locations (1)

680017

University of Nebraska, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT02759861 - Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics | Biotech Hunter | Biotech Hunter